Robert Barrow, CEO: Definium Therapeutics DFTX Sell · Filed 25/03/26

Trade details

Type: Insider sale
Amount: $142,941.92
Shares · price: 21,208 sh · $6.74 a share
Held after: 856,556 sh
Stock: Definium Therapeutics DFTX
Person: Robert BarrowCEO
Trade date: 25/03/25
Filed: 25/03/26
Days to filing: 1 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Definium Therapeutics trades, last 26 weeks

What else happened in Definium Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/23~25/04/24

Robert Barrow's recent trades

Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/29
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/25
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$718.1K
19,023 sh
$718.1K
Filed 09/03
Traded 09/03
Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.3M
29,208 sh
$1.3M
Filed 06/26
Traded 06/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
29,208 sh
$1.2M
Filed 06/25
Traded 06/25

Robert Barrow, CEO — sold $142.9K of Definium Therapeutics DFTX · 2.4% of holdings · 10b5-1 plan | Whalegun